The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy

NCT01842581 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

222

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Encephalopathy
Cirrhosis

Interventions

DRUG: Rifaximin
DRUG: Lactulose

Sponsor

Bausch Health Americas, Inc.